How does LXB's PS Ratio compare to its peers?

LXB is expensive based on its Price-To-Sales Ratio (16.4x) compared to the peer average (3.2x).

How does LXB's PS Ratio compare vs other companies in the SE Medical Equipment Industry?

LXB is expensive based on its Price-To-Sales Ratio (16.4x) compared to the Swedish Medical Equipment industry average (4.9x).

What is LXB's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate LXB's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of LXB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate LXB's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

LXB Stock Overview

A technology company, develops and commercializes X-ray tubes, generators, and X-ray systems to system suppliers. More details

LXB fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Risk Analysis

Makes less than USD$1m in revenue (SEK6M)

Earnings have declined by 18.3% per year over past 5 years

Shareholders have been substantially diluted in the past year

Does not have a meaningful market cap (SEK91M)

+ 1 more risk

My Notes

Capture your thoughts, links and company narrative

Luxbright AB (publ) Competitors

Clinical Laserthermia Systems

OM:CLS B

SEK 74.2m

Prolight Diagnostics

NGM:PRLD

SEK 92.7m

Medclair

NGM:MCLR

SEK 104.8m

IRRAS

OM:IRRAS

SEK 181.7m

Price History & Performance

Summary of share price highs, lows and changes for Luxbright
Historical stock prices
Current Share Price	SEK 0.81
52 Week High	SEK 1.30
52 Week Low	SEK 0.36
Beta	0.44
1 Month Change	-14.36%
3 Month Change	-18.69%
1 Year Change	72.38%
3 Year Change	-62.56%
5 Year Change	n/a
Change since IPO	-70.73%

Recent updates

Shareholder Returns

	LXB	SE Medical Equipment	SE Market
7D	10.3%	0.4%	-2.7%
1Y	72.4%	-8.1%	4.6%

Return vs Industry: LXB exceeded the Swedish Medical Equipment industry which returned -8.1% over the past year.

Return vs Market: LXB exceeded the Swedish Market which returned 4.6% over the past year.

Price Volatility

Is LXB's price volatile compared to industry and market?
LXB volatility
LXB Average Weekly Movement	9.1%
Medical Equipment Industry Average Movement	6.9%
Market Average Movement	5.6%
10% most volatile stocks in SE Market	11.3%
10% least volatile stocks in SE Market	3.2%

Stable Share Price: LXB's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: LXB's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

Founded	Employees	CEO	Website
2012	10	Mats Alm	www.luxbright.com

Luxbright AB (publ), a technology company, develops and commercializes X-ray tubes, generators, and X-ray systems to system suppliers. Its products are used in the areas of industrial NDT, and medical radiology and research, as well as in the security industry. The company was incorporated in 2012 and is headquartered in Västra Frölunda, Sweden.

Luxbright AB (publ) Fundamentals Summary

How do Luxbright's earnings and revenue compare to its market cap?
LXB fundamental statistics
Market cap	SEK 90.71m
Earnings (TTM)	-SEK 22.23m
Revenue (TTM)	SEK 5.53m

16.4x

P/S Ratio

-4.1x

P/E Ratio

Is LXB overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LXB income statement (TTM)
Revenue	SEK 5.53m
Cost of Revenue	SEK 2.98m
Gross Profit	SEK 2.55m
Other Expenses	SEK 24.78m
Earnings	-SEK 22.23m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.20
Gross Margin	46.10%
Net Profit Margin	-401.98%
Debt/Equity Ratio	0.8%

How did LXB perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 15:49
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Luxbright AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution